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Background: Morgellons disease is a controversial illness in which patients complain of 
  stinging, burning, and biting sensations under the skin. Unusual subcutaneous fibers are the 
unique objective finding. The etiology of Morgellons disease is unknown, and diagnostic cri-
teria have yet to be established. Our goal was to identify prevalent symptoms in patients with 
clinically confirmed subcutaneous fibers in order to develop a case definition for Morgellons 
disease.
Methods: Patients with subcutaneous fibers observed on physical examination (designated 
as the fiber group) were evaluated using a data extraction tool that measured clinical and 
demographic characteristics. The prevalence of symptoms common to the fiber group was 
then compared with the prevalence of these symptoms in patients with Lyme disease and no 
complaints of skin fibers.
Results: The fiber group consisted of 122 patients. Significant findings in this group were 
an association with tick-borne diseases and hypothyroidism, high numbers from two states 
(Texas and California), high prevalence in middle-aged Caucasian women, and an increased 
prevalence of smoking and substance abuse. Although depression was noted in 29% of the 
fiber patients, pre-existing delusional disease was not reported. After adjusting for nonspecific 
symptoms, the most common symptoms reported in the fiber group were: crawling sensations 
under the skin; spontaneously appearing, slow-healing lesions; hyperpigmented scars when 
lesions heal; intense pruritus; seed-like objects, black specks, or “fuzz balls” in lesions or on 
intact skin; fine, thread-like fibers of varying colors in lesions and intact skin; lesions contain-
ing thick, tough, translucent fibers that are highly resistant to extraction; and a sensation of 
something trying to penetrate the skin from the inside out.
Conclusions: This study of the largest clinical cohort reported to date provides the basis for 
an accurate and clinically useful case definition for Morgellons disease.
Keywords: Morgellons, subcutaneous fibers, pruritus, delusions of parasitosis, Lyme disease, 
skin lesions
Introduction
Morgellons disease is a poorly understood multisystem illness characterized by stinging, 
biting, and crawling sensations under the skin.1 According to the Morgellons Research 
Foundation (MRF) website, more than 14,000 families are reportedly affected by this 
emerging disease.2 Considerable suffering occurs as thread-like fibers work their way 
out of the victim’s skin causing pain, itching, and open, disfiguring lesions (Figures 
1 and 2). Unfortunately, patients are often dismissed as delusional by clinicians who 
are unfamiliar with the signs and symptoms of Morgellons disease.3–5 There is a scar-
city of literature on Morgellons disease due to its relatively recent description in the Clinical, Cosmetic and Investigational Dermatology 2010:3 68
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modern medical literature, the reluctance on the part of the 
medical community to recognize it as anything other than 
psychopathology, and the lack of knowledge about its etiol-
ogy and transmission.6
The distinctive feature of Morgellons disease is the 
  presence of microscopic subcutaneous fibers1 (Figures 3, 
4, and 5). Observation of the skin with a lighted, hand-
held, 30 × to 60 × magnifier enables visualization of these 
red, blue, black, and white fibers that have the appearance 
of either straight hollow tubes or wiry tangled threads.1 
At times the fibers are seen above the dermis as loosely 
clumped “fuzz balls” or as black specks the size of cof-
fee grains. Examination of the black specks by electron 
microscopy reveals that they consist of a tightly woven ball 
of black fibers.6
Biopsies performed on Morgellons disease patients 
have focused on fibrous material projecting from inflamed 
epidermal tissue, and this material is often labeled as “textile 
fibers” on pathologic examination.7 However, a more thor-
ough analysis of the fibers performed by the Federal Bureau 
of Investigation forensics laboratory has revealed that the 
fibers do not resemble textiles or any other manmade sub-
stance. In fact, the fibers are virtually indestructible by heat 
or chemical means, making analysis difficult by conventional 
methods.6
In order to identify a homogeneous population for 
research purposes, it is important to develop a clinically-
based case definition for Morgellons disease. To this end, we 
studied a group of subjects selected for a unique inclusion 
criterion in order to describe demographic, comorbidity, 
and symptom characteristics common to the population of 
Morgellons patients.
Figure 1 Morgellons patient’s lower legs. Similar lesions covered her trunk and arms. 
There were no excoriations or secondary infections. Photo courtesy of Cindy Casey, 
Charles E Holman Foundation,   Austin, Texas. Reproduced with permission.
Materials and methods
Design and approval
The study was conducted using a one-group, retrospective 
design with one data collection episode. The Declaration of 
Helsinki protocols were followed, and approval for the study 
was obtained from the Case Western Reserve Institutional 
Figure 2 Morgellons patient’s back. Note that lesions and scars occur in areas that 
could not have been reached by the patient. Photo courtesy of Cindy Casey, Charles 
E Holman Foundation,   Austin, Texas. Reproduced with permission.
Figure 3 Close up of a leg lesion showing a twisted fiber just under the epidermis. 
Magnification 100 ×. Photo courtesy of Cindy Casey, Charles E Holman Foundation, 
Austin, Texas. Reproduced with permission.Clinical, Cosmetic and Investigational Dermatology 2010:3 69
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Review Board, Cleveland, Ohio. Written informed consent 
was obtained from all study subjects for review of their 
medical records, and patient anonymity and confidentiality 
were strictly maintained. An epidemiologist provided input 
for the study design.
Patient sample
The convenience sample included all patients seen in the 
first author’s San Francisco medical office who met the 
inclusion criterion. The subject inclusion criterion was a 
positive examination for microscopic subcutaneous fibers as 
visualized by the first author using a 60 × handheld lighted 
magnifier. There were no exclusion criteria for the sample 
group because the inclusion criterion was narrowly defined 
to promote a homogeneous sample.
Intervening variables identified for the study were smok-
ing, substance abuse, immunosuppressive therapy, clinical 
comorbidities, and prescription medications. These variables 
had been identified in a pilot study (n = 44) that was con-
ducted by the first author in March of 2005 to gather prelimi-
nary information about Morgellons disease patients.
Procedure
Five content experts reviewed and agreed upon the 
  demographic, health background, and symptom data extrac-
tion tools developed by the first author (see Appendix A). The 
experts included two internists, a family practitioner, an infec-
tious disease specialist, and a psychiatrist. All had clinical 
experience with the diagnosis and treatment of Morgellons 
disease. The experts were provided with a list of variables 
to be recorded for each study subject and were asked to rate 
each variable for its relevance to the illness and the study 
population. The experts agreed with at least 80% consistency 
regarding the degree of relevancy of each variable in the data 
extraction tools for the Morgellons disease population.8
Medical records of all patients meeting the inclusion 
criterion were identified by the first author. Positive serologic 
testing for Borrelia burgdorferi or a high degree of suspicion 
for Lyme disease was noted on the patient questionnaire in 
the chart. Because Lyme disease testing is known to be insen-
sitive,9 the Centers for Disease Control and Prevention has 
recommended that the diagnosis be based upon the clinical 
judgement of the health care provider rather than the results 
of a laboratory test. Therefore, criteria for “a high degree of 
suspicion for Lyme disease” were agreed upon by a panel 
of three Lyme disease specialists, and included at least five 
of the following seven findings: history of tick bite and/or 
“bullseye” rash; strong exposure potential in a high-risk 
environment in an endemic area; an equivocal Lyme West-
ern blot result or the presence of bands highly specific for 
B burgdorferi on an otherwise negative Western blot;10 posi-
tive tick co-infection tests including babesiosis, ehrlichiosis, 
anaplasmosis, and/or bartonellosis:11 a below-normal CD57 
natural killer cell count;12 an above-normal C4a complement 
protein;13 and classic Lyme disease symptoms such as joint 
pain, exhaustion, and mental confusion.
A medical assistant in the first author’s office photocopied 
the patient questionnaires, concealed the identities, num-
bered them for identification, and provided these to the first 
author. The first author then completed the data extraction 
tools for each study subject using information gathered from 
Figure 4 Black fibers and one red fiber, just under the epidermis of a healing lesion. 
Magnification 200 ×. Photo courtesy of Cindy Casey, Charles E Holman Foundation, 
Austin, Texas. Reproduced with permission.
Figure 5 Fiber under epidermis (top) and separate from a skin lesion (bottom).   
Magnification 30 ×. Photo courtesy of Randy Wymore, Oklahoma State University 
Center for Health Sciences, Tulsa, Oklahoma. Reproduced with permission.Clinical, Cosmetic and Investigational Dermatology 2010:3 70
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these questionnaires. To validate reliability and consistency 
of data extraction, a volunteer medical assistant randomly 
checked 10 data collection tools against their corresponding 
questionnaires. Consistency of data extraction was verified. 
The Statistical Package for the Social Sciences, version 16, 
was used for data analysis.
When clinical results demonstrated that 97% of the 
study sample had evidence of coexisting Lyme disease, 
a questionnaire about prevalent symptoms in the fiber 
group was administered to 60 Lyme disease patients 
who had no complaints of skin fibers. The convenience 
sample of 60 volunteers was recruited by an email that 
was sent to 116 of the first author’s current and former 
Lyme patients. All patients who volunteered were evalu-
ated for symptom prevalence. Results of the Lyme group 
were tabulated and, to compare the symptoms of the two 
groups, a Friedman chi square analysis was performed 
using GraphPad InStat Version 3.0b software (GraphPad 
Software, La Jolla, CA).
Results
Patient characteristics
In the Morgellons group, the 122 subjects were predomi-
nantly female (n = 103, 84.4%) with a mean age of 47.8 years 
(SD = 12.13, range 22–85). The median age was 48.5 years 
and the mode was 45 years. Subjects (n = 110) overwhelm-
ingly identified as white/non-Hispanic (90.2%). The only 
other races represented were Hispanic (n = 8, 6.6%) and 
African American (n = 4, 3.2%).
Of the 122 subjects, 23 different states of resi-
dence were represented and one foreign nationality, the 
United Kingdom. The states of residence most frequently 
reported were California (n = 58, 47.5%) and Texas 
(n = 24, 19.7%). There were six subjects from New York, 
four from Florida and one or two subjects from other states 
including Alabama, Arizona, Colorado, Illinois, Indiana, 
Louisiana, Maryland, Michigan, Minnesota, Missouri, North 
Carolina, New Jersey, Nevada, Ohio, Oregon, Tennessee, 
Utah, Virginia, and Washington.
The occupations of Morgellons subjects are shown 
in Table 1. The majority of subjects were unemployed 
(n = 54, 44.3%), including those who were homemakers, 
retired, involuntarily unemployed, or on disability leave. 
The next most frequent occupation (n = 15, 12.3%) was 
  professionals who worked indoors, such as accountants, attor-
neys, and business managers. Following close behind in fre-
quency were office workers, such as administrative assistants 
(n = 13, 10.7%) and health care workers, including nurses and 
massage therapists (n = 10, 8.2%). Other occupations repre-
sented in smaller numbers were, in descending order, sales, 
outdoor manual laborers, teachers, outdoor professionals, 
indoor manual laborers, and technical workers.
Thirty-two percent (n = 39) of the sample reported 
smoking cigarettes. A history of previous substance abuse 
was reported by 12.3% (n = 15), but all subjects reported 
being in full recovery from substance dependence at the 
time of completion of their questionnaires. Five subjects 
(4.1%) reported being on immunosuppressive therapy at 
the time of their onset of illness. Eighteen percent (n = 22) 
of subjects indicated that at least one other family member 
shared similar symptoms.
Length of symptoms at time of presentation to the clinic 
ranged from one month to 624 months (52 years) with a median 
length of symptoms of 18 months and mode of 39 months. 
With the exception of two outliers (the subject who had been 
sick for 52 years and another who had been sick for 30 years), 
length of symptoms ranged from one month to 20 years.
Comorbidities
At the time of presentation to the clinic 28.7% (n = 35) of the 
sample was on treatment for depression and 22.1% (n = 27) 
had been diagnosed with hypothyroidism. Nineteen of the 
subjects (15.6%) reported problems with allergic rhinitis 
and/or asthma. Other comorbidities occurring at lower rates 
are noted in Table 2.
Sixty-four (52.5%) of the subjects had positive Lyme tests 
by Western blot. Another 44.3% (n = 54) were highly suspect 
for Lyme disease based on the presence of 5/7 of the defined 
criteria for a Lyme diagnosis, as outlined in the Materials and 
methods section. These results imply that 96.8% of the sample 
may have been infected with B burgdorferi, the spirochetal 
Table 1 Occupation of subjects at the time of presentation to 
the clinic (n = 122)
Occupation Number (n)
Unemployed 54
Professional (indoor) 15
Office worker 13
Health care worker 10
Sales 9
Outdoor manual laborer 6
Teacher 6
Professional (outdoor) 4
Indoor Manual Labor 4
Technical Worker 1Clinical, Cosmetic and Investigational Dermatology 2010:3 71
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agent of Lyme disease. Positive tests for tick-borne co-infec-
tions noted in the sample were Babesia microti or Babesia 
duncani (n = 22, 18%), Anaplasma phagocytophilum (n = 13, 
10.7%), Ehrlichia chaffeensis (n = 12, 9.8%), and Bartonella 
henselae (n = 12, 9.8%).
The medications that subjects were taking at the time 
of their questionnaire completion are listed in Table 3. Of 
note is that 29.5% were on antidepressants and 20.5% were 
receiving thyroid supplementation. Precipitating events 
associated with the onset of symptoms are listed in Table 4. 
Although a variety of precipitating events was reported, 
in many cases (n = 29, 23.8%) subjects were unaware 
of an association of any event with the initiation of their 
symptoms. The most frequent events were, in descending 
order: an infestation of biting insects such as lice or fleas 
(n = 17, 13.9%); recent visit to a third world country (n = 
15, 12.3%); a splinter, thorn, or dirty cut (n = 14, 11.5%); 
and working in dirt or exposure to dirty water (each n = 
13, 10.7%). All of these risk factors involve exposure to 
unclean situations.
The diagnoses given to subjects for their presenting symp-
toms are shown in Table 5. The most common diagnosis was 
delusions of parasitosis (n = 55, 45.1%). Other diagnoses, 
in descending order, were: scabies (n = 20, 16.4%); atopic 
dermatitis (n = 15, 12.3%); impetigo (n = 12, 9.8%); stress 
reaction (n = 9, 7.4%) and miscellaneous diagnoses.
Specific and nonspecific symptoms 
and their frequencies
Symptoms common to the Morgellons group are shown 
in Table 6. A total of 19 symptoms were reported by more 
than 70% of patients in this group. Because 97% of the 
study sample had probable Lyme disease, a questionnaire 
about symptoms noted in the fiber group was administered 
to 60 patients with Lyme disease and no complaints of skin 
fibers. Although the Lyme sample was not expressly matched 
with the Morgellons group, the demographics proved to be 
similar. The Lyme patient sample was 87% female, 97% 
white, non-Hispanic (3% Hispanic) and the age range was 
16–62 years with a mean age of 43 years.
Table 7 shows the symptom prevalence in the Morgellons 
and Lyme groups. Based on Friedman’s chi square analysis, 
26 symptoms were shown to be significantly more common 
in the patients with fibers, five symptoms were shown to be 
significantly more common in the Lyme disease patients, 
and five symptoms were not significantly different in the 
two groups (Table 8).
Following adjustment for symptoms that were not specific 
to the Morgellons group, the most common specific symp-
toms shared by more than 70% of the Morgellons patients 
were, in descending order of frequency: crawling sensations 
under the skin; spontaneously appearing, slow-healing 
Table 2 Comorbidities of subjects (n = 122)
Illness Number (n) % of sample
Lyme (+ Western Blot) 64 52.5
Lyme (high suspicion) 54 44.3
Depression 35 28.7
Hypothyroid 27 22.1
Babesiosis 22 18.0
Allergic rhinitis/asthma 19 15.6
Hypertension 14 11.5
Anaplasmosis 13 10.7
Bartonellosis 12 9.8
Ehrlichiosis 12 9.8
Fibromylagia 8 6.6
Attention deficit disorder 8 6.6
Anemia 7 5.7
Sleep disorder 7 5.7
Chronic fatigue syndrome 5 4.1
Heart disease 5 4.1
Arthritis 4 3.3
Diabetes 4 3.3
Celiac disease (gluten intolerance) 3 2.5
H pylori infection 3 2.5
Autoimmune disease 3 2.5
Table 3 Medications taken by subjects (n = 122)
Medication Number taking it % of sample
Antidepressant 36 29.5
Thyroid 25 20.5
Antihypertensive 21 17.2
Antihistamine 14 11.5
Pain medication 14 11.5
Anxiolytic 13 10.7
Statin 5 4.1
Steroid 4 3.3
Glucophage 3 2.5
Attention deficit disorder  
medication
2 1.6
Anti-epileptic 2 1.6
Female hormones 2 1.6
Muscle relaxant 1 0.8
Retroviral 1 0.8
Ropinirole (restless leg  
syndrome)
1  0.8 Clinical, Cosmetic and Investigational Dermatology 2010:3 72
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lesions; hyperpigmented scars when lesions heal; intense 
pruritus; seed-like objects emerging from skin; black specks 
appearing on the skin; “fuzz balls” on intact skin; fine, thread-
like fibers of varying colors in lesions and intact skin; lesions 
with thick, tough, translucent fibers that are highly resistant to 
extraction; and a sensation of something trying to penetrate 
the skin from the inside out.
Discussion
The primary goal of our study was to identify the most com-
mon symptoms in patients with documented subcutaneous 
fibers who were seen in a medical practice. The study sample 
Table 4 Events precipitating initiation of subjects’ symptoms   
(n = 122)
Event Number (n) % of sample
Unknown/not sure 29 23.8
Lice and flea infestation 17 13.9
Recent travel to third-world  
country
15 12.3
Splinter, cut or thorn 14 11.5
Exposure to dirty water 13 10.7
Working in dirt 13 10.7
Life stress 7 5.7
Tick/insect bite 6 4.9
Camping 6 4.9
Post surgical 4 3.3
Animal bite 3 2.5
Post severe burn 1 0.8
Initiation of steroid therapy 1 0.8
Exposure to a person with like 
symptoms
1  0.8 
Table 5 Diagnoses given to study subjects prior to presentation 
to first author’s clinic (n = 122)
Diagnosis Number (n) % of sample
Delusions of parasitosis 55 45.1
Scabies 20 16.4
Atopic dermatitis 15 12.3
Impetigo 12 9.8
Stress reaction 9 7.4
Neurodermatitis 5 4.1
Self-mutilation 4 3.3
Lice 4 3.3
Folliculitis 4 3.3
Obsessive-compulsive disorder 2 1.6
Fungal infection 2 1.6
Acne 1 0.8
Psoriasis 1 0.8
Table 6 Symptoms of patients with a positive exam for 
  subcutaneous fibers (n = 122)
% of sample Number (n)  Symptom
98 118 Crawling sensations under the 
skin
95 116 Spontaneously-appearing, slow-
healing skin lesions
91 111 Fatigue that interferes with 
activities of daily living
90 110 Sleep irregularities
89 109 Hyperpigmented scars when 
lesions heal
87 106 Intense pruritus, even before 
lesions appear
86 105 Brain fog (problems thinking, 
remembering, etc.)
84 103 Seed-like objects coming out  
of the skin
84 102 Black specks appearing  
spontaneously on the skin
82 100 Unusual irritability
80 97 Symptoms worse when hot
79 96 “Fuzz balls” (white or blue)  
on skin
78 95 Muscle pain
78 94 Joint pain
77 94 Weakness
77 94 Thin, thread-like fibers under or 
protruding from skin
77 94 Symptoms worse at night
74 90 Thick, tough, difficult-to-extract, 
white or clear fibers
71 87 Sensation of things poking 
through skin
69 84 Feeling of hopelessness
65 79 Awareness of tiny insects flying 
around head
62 75 New onset of anxiety or panic 
attacks
61 74 Fibers or filaments move
60 73 Slimy film on skin
59 72 “Sand” in bed upon awakening
57 70 Brown flakes in bed upon 
awakening
57 70 Fibers in mucous membranes 
(mouth, nose, eyes)
57 69 Awareness of objects racing 
across eyes
56 68 Soft mounds on head
56 68 Dramatic weight change
53 65 Fibers under finger and toe nails
53 65 Significant hair loss
(Continued )Clinical, Cosmetic and Investigational Dermatology 2010:3 73
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consisted primarily of middle-aged Caucasian patients, but 
because the first author’s clinic does not accept insurance, 
the sample may have been biased toward an upper-middle 
class socioeconomic group. This in turn may have predis-
posed toward Caucasian race and older, more economically 
stable subjects.
The sample was predominantly female, which engen-
ders speculation as to the reason for this prevalence. This 
finding differs from that of the MRF, which reports an 
equal number of males and females in their database of 
self-diagnosed Morgellons cases.2 There are other illnesses, 
such as multiple sclerosis, hypothyroidism, and numer-
ous autoimmune diseases that appear to affect primarily 
women. Furthermore, female predominance has been noted 
in patients with persistent symptoms of Lyme disease.14 
Gender differences in human disease susceptibility are usu-
ally attributed to either physiologic or sociologic causes. 
The physiologic causes are usually hormonal in origin.15 
Examples of sociologic causes are different exposure to 
pathogens because of gender-specific behavior and differ-
ent tendencies to present for medical care, leading to the 
appearance of a skewed demographic.15 Any of these factors 
are plausible in Morgellons disease.
It may seem surprising that a complaint of skin fibers 
was reported by only 77% of the sample. A plausible expla-
nation is that the fibers typical of Morgellons disease are 
microscopic, and in many cases subjects had not employed a 
magnification system to visualize their skin. Of note is that 
the seed-like objects and black granules reported by these 
patients are visible on the surface of the skin without 
the use of magnification. This fact probably explains why 
these symptoms were reported more frequently than the 
presence of fibers.
Of the 122 study subjects, most were from California and 
Texas, possibly due to the fact that these are the two states 
where the first author had lived and practised. However, the 
MRF maintains that California, Texas, and Florida are the 
states where Morgellons disease is most prevalent, based 
upon registrants on the MRF web site.2 A common feature 
shared by these states is that they have the most mileage of 
coastline, prompting speculation that the putative infectious 
agent of Morgellons disease could be water-borne. California 
and Texas are also two of the states with the highest number 
Table 6 (Continued )
% of sample Number (n)  Symptom
52 63 Deteriorating teeth or jaw 
(unexplainable by dentist)
45 55 Black tar-like fluid comes out 
through pores
40 49 Hair texture feels different, 
abnormal
37 45 No hair growth
30 37 Female problems (pelvic pain, 
irregular menses)
29 35 Bald patches on head
Table 7 Comparison of symptom prevalence in Morgellons group 
(n = 122) and Lyme group (n = 60)
Symptom  Morgellons  
group (n[%])
Lyme group   
(n[%])
Crawling sensations 118 (98%) 19 (32%)
Skin lesions 116 (95%) 5 (8%)
Fatigue 111 (91%) 58 (97%)
Sleep irregularities 110 (90%) 60 (100%)
Hyperpigmented scars 109 (89%) 6 (10%)
Intense pruritus 106 (87%) 20 (33%)
Brain fog 105 (86%) 60 (100%)
Seed like objects 103 (84%) 0 (0%)
Black specks 102 (84%) 0 (0%)
Unusual irritability 100 (82%) 47 (78%)
Symptoms worse when hot 97 (80%) 19 (32%)
“Fuzz balls” on skin 96 (79%) 0 (0%)
Muscle pain 95 (78%) 57 (95%)
Joint pain 94 (78%) 58 (97%)
Weakness 94 (77%) 58 (97%)
Thin, thread-like fibers in skin 94 (77%) 0 (0%)
Skin symptoms worse at night 94 (77%) 15 (25%)
Thick, tough filaments 90 (74%) 0 (0%)
Sensation of poking 87 (71%) 3 (5%)
Hopelessness 84 (69%) 49 (82%)
Awareness of tiny insects 79 (65%) 5 (8%)
New onset anxiety 75 (62%) 40 (67%)
Fibers, filaments move 74 (61%) 0 (0%)
Slimy or waxy film 73 (60%) 0 (0%)
“Sand” in bed 72 (59%) 0 (0%)
Brown flakes in bed 70 (57%) 0 (0%)
Fibers in mucous membranes 70 (57%) 0 (0%)
Objects racing across eyes 69 (57%) 21 (35%)
Mounds on head 68 (56%) 2 (3%)
Dramatic weight change 68 (56%) 30 (50%)
Fibers under nails 65 (53%) 0 (0%)
Significant hair loss 65 (53%) 22 (37%)
Deteriorating teeth/jaw 63 (52%) 15 (25%)
Black, tar-like 55 (45%) 0 (0%)
Hair texture abnormal 49 (40%) 0 (0%)
No hair growth 45 (37%) 0 (0%)Clinical, Cosmetic and Investigational Dermatology 2010:3 74
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Table 8 Chi square analysis of symptom prevalence in Morgellons 
group versus Lyme group
Significantly more common in the Morgellons group
Symptom P value
Crawling sensations 0.0001
Lesions spontaneously appear on skin 0.0001
Severe itching 0.0001
Hyperpigmented scars 0.0001
Seed like objects coming out of skin 0.0001
Black specks on skin 0.0001
Symptoms worse when hot 0.0001
“Fuzz balls” on skin 0.0001
Thin thread-like fibers 0.0001
Symptoms worse at night 0.0001
Thick, tough fibers 0.0001
Poking sensations through skin 0.0001
Insects flying around head 0.0001
Fibers move 0.0001
Slimy film on skin 0.0001
“Sand” in bed 0.0001
Brown flakes in bed 0.0001
Fibers in mucous membrane 0.0001
Soft mounds on head 0.0001
Fibers under nails 0.0001
Black tar like exudates 0.0001
Abnormal hair texture 0.0001
No hair growth 0.0001
Deteriorating teeth/jaw 0.0008
Objects racing across eyes 0.0074
Significant hair loss 0.0407
Significantly more common in the Lyme group  
Joint pain 0.0005
Weakness 0.0005
Brain fog 0.0009
Muscle pain 0.0027
Sleep disturbances 0.0094
No significant difference between the two groups
Extreme fatigue NS
Irritability NS
Hopelessness NS
New onset of anxiety NS
Significant weight change NS
of Hispanic immigrants. It is not known whether this may 
have a bearing on the high prevalence of the disease in these 
states, but recent third-world travel was found in this study to 
be a risk factor for the development of Morgellons disease. 
Furthermore, California and Texas are among the states with 
the highest average yearly temperatures according to the 
National Weather Service (http://usaresearch.gov/search) and 
rarely, if ever, endure hard freezes in the winter. The resultant 
warm weather may sustain the ability of certain types of 
pathogens to survive. The definitive reason for the high 
prevalence of Morgellons disease in Texas and California 
remains to be determined.
Of note is the high percentage of subjects (32%) who 
reported smoking cigarettes. According to 2006 statistics 
from the Centers for Disease Control and Prevention’s 
National Center for Health Statistics, 17.8% of a 
similarly-matched population of adult females smoke 
cigarettes. Smoking can impair immune function, par-
ticularly in areas heavily perfused by microvasculature, 
such as the skin.16 Smoking may also have been more 
prevalent in the study population as a result of the extreme 
emotional stress that Morgellons patients endure. Our 
data did not differentiate between those who had been 
smoking before their illness and those who began smok-
ing as a result of it.
According to a 2003 National Survey on Drug Use and 
Health, an estimated 5.9% of women over 18 years met 
  criteria for substance abuse within the year prior to the sur-
vey’s data collection. Slightly more than twice that percentage 
of the study sample (12.3%) reported a history of substance 
abuse. It is known that taking certain drugs such as amphet-
amines or withdrawing from them may cause sensations of 
“bugs crawling on the skin”, and the sample’s relatively high 
percentage of subjects with a history of substance abuse could 
be used to support the argument that Morgellons disease is 
simply a psychologic or drug-induced state. However, it is 
equally important to note that 87.7% of study subjects had 
no history of substance abuse.
Most patients reported no symptoms in their loved 
ones despite the fact that they continued to sleep with their 
spouses and care for their children throughout their illnesses. 
However, 18% of this sample (n = 22) reported at least one 
family member with similar symptoms. For most of these 
22 subjects, the pre-illness exposure that they reported could 
have been a common exposure for other family members. 
Furthermore, family members reported as having symptoms 
were not interviewed or examined by the first author and may 
not have actually had Morgellons disease. It remains unclear 
as to whether there is a contagious component to Morgellons 
disease or whether symptoms shared by family members 
imply a common exposure source.
Depression was reported by 28.7% of the study sample 
and antidepressants were the most common medications Clinical, Cosmetic and Investigational Dermatology 2010:3 75
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taken. The lifetime prevalence of depression in the US is 
estimated to be as much as 17% of the general population,17 so 
the rate of depression seen in this population does not appear 
to be particularly high considering that subjects were suffer-
ing from a misunderstood and debilitating chronic medical 
condition. Furthermore, since many patients with Morgel-
lons disease are referred to psychiatrists, significantly more 
patients with psychological diagnoses would be expected in 
this group.
The prevalence of delusional disorder in the US is esti-
mated to be about 0.03%, and a similarly low prevalence is 
found in other societies.18,19 A review of the backgrounds of 
3,000 self-reported cases of Morgellons disease found pre-
existing delusional disorders to be no more prevalent than 
would be expected in the general population.20 Nevertheless, 
patients with symptoms of Morgellons disease are routinely 
dismissed as delusional.7 The present study reinforces the 
fact that Morgellons patients appear to be distinct from 
patients with delusional disorders in terms of demographics 
and symptomatology.
Thyroid medication was the second most common medi-
cation taken by the study subjects (20.5%) and 22.1% of the 
sample claimed to have been diagnosed with hypothyroidism. 
Considering that about 3% to 8% of adults in the general popu-
lation are hypothyroid,21 this prevalence in the study group 
appears to be high. The predominantly middle-aged, female 
demographic of the study group may have influenced this 
finding, since hypothyroidism is more prevalent in females 
than in males and in older adults than younger adults.21
Should future research duplicate the finding of a high 
prevalence of hypothyroidism in Morgellons patients, it 
would be worthwhile to distinguish between those who 
were hypothyroid before their Morgellons disease symptoms 
appeared and those who developed it afterwards. Thyroid 
antibody testing would also be helpful in order to differentiate 
those who are hypothyroid due to autoimmune thyroiditis. 
Infections may play a role in autoimmunity,22 suggesting that 
hypothyroidism could be a consequence of infection with the 
putative agent of Morgellons disease. Because we did not 
differentiate between Morgellons patients and Lyme patients 
with regard to hypothyroidism, B burgdorferi infection may 
have played a role in this comorbidity as well. Homologies 
between thyroid antigens and borrelial proteins have been 
described,23 suggesting that coexisting Lyme disease may 
trigger thyroid dysfunction in genetically susceptible Morg-
ellons patients.
A provisional case definition for Morgellons disease 
consisting of nine symptoms has been developed by the 
MRF based on self-reported cases.2 Based on the findings 
of the current study, five of the symptoms in the MRF 
provisional case definition for Morgellons disease appear 
to be nonspecific. These five symptoms are severe fatigue, 
problems with cognition, musculoskeletal pain, aerobic 
limitation, and behavioral changes. Of note, these symptoms 
are frequently reported in patients with chronic Lyme dis-
ease (Table 7). Thus the symptoms may reflect the presence 
of both conditions rather than being specific markers for 
Morgellons disease.
The high rate of tick-borne diseases in our sample is 
intriguing and prompts speculation as to whether the putative 
agent of Morgellons disease could be tick-borne.24 Another 
possibility is that infection with B burgdorferi may predispose 
a victim to other illnesses such as Morgellons disease. This 
phenomenon is observed, for example, in the prevalence of 
virally-induced (and otherwise rare) Kaposi’s sarcoma in 
patients with acquired immune deficiency syndrome.25 The 
association between Morgellons diseae and Lyme disease 
merits further study.
Summary
The primary purpose of this study was to elucidate the 
symptoms common to patients with a positive examination 
for subcutaneous fibers in order to develop an accurate and 
clinically useful case definition for Morgellons disease. After 
adjusting for symptoms that were nonspecific to the fiber 
group, the most common symptoms shared by more than 
70% of the study sample were: crawling sensations under 
the skin; spontaneously appearing, slow-healing lesions; 
hyperpigmented scars when lesions heal; intense pruritus; 
seed-like objects and black specks coming out of the skin; 
“fuzz balls” on intact skin; fine, thread-like fibers of varying 
colors in lesions and intact skin; lesions with thick, tough, 
translucent fibers that are highly resistant to extraction; and 
a sensation of something trying to penetrate the skin from 
the inside out.
Other significant findings in the study sample that war-
rant further investigation are the association with tick-borne 
diseases and hypothyroidism, high numbers from two states 
(Texas and California), high prevalence in middle-aged 
Caucasian women, and a higher-than-average history of 
substance abuse.
This is the first group of clinician-defined Morgel-
lons subjects to be described in detail. The strength of the 
study lies in the size of the sample and the unique and 
clearly defined inclusion criterion that virtually rules out 
confounding variables. Further study of etiological factors Clinical, Cosmetic and Investigational Dermatology 2010:3 76
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and symptom prevalence in this emerging multisystem illness 
is warranted.
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Appendix A
I. Demographic data extraction tool.
Completed by the primary investigator.
Subject ID # _____
Gender: Male = 0 Female = 1
Age in years: _______
Ethnicity: 
1. Caucasian   3. Hispanic
2. African-American  4. Asian
State of Residence –––––––––––––––––––––––––––––––
Postal Code for State: –––––––––––––––––––––––––––––
Occupation at time of illness onset: _________________
Circle appropriate type of occupation based on above:
  1. Unemployed, retired or on disability
  2. Office worker
  3. Health care worker
  4. Professional
  5. Outdoor manual lab
  6. Indoor manual labor
  7. Sales
  8. Teacher
  9. Technical
10. Other
II. Health background data extraction tool.
Completed by the primary investigator.
Smoker? NO = 0 YES = 1
Substance abuse problem: NO = 0 YES = 1
On immunosuppressive therapy? NO = 0 YES = 1
Family members with same symptoms? NO = 0 YES = 1
Length of time in months the patient had symptoms 
before initial visit?
______years _______ mos TOTAL TIME IN MONTHS 
(with 0 fill) _______
COMORBIDITIES:  Circle: 0 for NO  1 for YES
Anaplasmosis  0  1
Anemia  0  1
Allergic rhinitis/asthma  0  1
Autoimmune disease  0  1
Babesiosis  0  1
Bartonellosis  0  1
Chronic fatigue syndrome  0  1
Depression  0  1
Ehrlichiosis  0  1
Fibromyalgia  0  1
Heart disease  0  1
Hypothyroid  0  1
Lyme (+ test)  0  1
Lyme, highly suspicious  0  1
Sleep disorder  0  1
Other (20 sp) ––––––––––––––––––––––––––––––––––––––––––------–
MEDICATION(S):  Circle: 0 for NO   1 for YES
Antihypertensive  0  1
Antidepressant  0  1
Antihistamine  0  1
Antiepileptic  0  1
Other (10 sp) –––––––––––––––––––––––––––––––––––––––––––––––
PRECIPITATING EVENT(S):  Circle: 0 for NO   1 for YES
Camping  0  1
Exposure to dirty water  0  1
Lice, flea infestation  0  1
Life stress  0  1
Post-surgical  0  1
Splinter, cut, thorn  0  1
Working in dirt  0  1
Unknown  0  1
Other (20 sp) –––––––––––––––––––––––––––––––––––––––––––––––
Diagnoses given  
for current symptoms:  Circle: 0 for NO   1 for YES
Delusions of parasitosis  0  1
Scabies   0  1
Impetigo  0  1
Folliculitis  0  1
Atopic dermatitis  0  1
Neurodermatitis  0  1
Drug-induced formications  0  1
Cutaneous sensory disease  0  1
Other (20 sp)–––––––––––––––––––––––––––––––––––––––––––––––
III. Symptom data extraction tool.
Completed by the primary investigator.
To the left of each symptom put a “0” if it was left blank 
in the original questionnaire and a “1” if it was checked off 
as present
  1____      Disfiguring lesions on skin which start like tiny 
pimples
  2____  Intense itching, even before the lesions appear
  3____    Feeling of crawling, biting and stinging under 
skin
  4____      Feeling something trying to poke through the skin 
from the inside
  5____  Lesions heal slowly and form brownish scars
  6____  Bald patches on your head
  7____  Hair loss
  8____  Hair that does not grow (same length for a long time)
  9____    When hair grows back on head it does not feel like 
it is yours
10____    Hair-like filaments from “wiggle” and move once 
extracted
11____    Hair-like filaments in tongue, throat, nose, ears, 
eyes (circle which)
12____    Black specks on skin, which when brushed aside, 
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13___ Film on skin (greasy, slimy)
14___ Soft mounds on skull, sometimes filled with fibers
15___   Tough, white, hard-to-extract filaments coming out of 
lesions
16___ Thin white filaments protruding through skin
17___ Tough filaments under finger and/or toe nails
18___ Black, tar-like exudates on the skin
19___   “Fuzz balls” on skin – blue, white, red or orange (circle 
which)
20___   Sensation of things racing across your eyes, affecting 
your vision
21___ Dried brown flakes on your bed sheets
22___   Sand-like objects present in bedclothes upon 
  awakening
23___ Frequent awareness of tiny flying insects around you
24___   Seed-like or granule-like objects associated with skin 
or lesions
25___   Dramatic increase in skin symptoms when hot or 
sweating
26___ Symptoms worse at night
27___ Deteriorating teeth or jaw
28___ Extreme fatigue
29___   Brain fog, memory problems, inability to concentrate 
or think
30___ Muscle aches
31___ Weakness
32___ Joint pain
33___ Disrupted sleep
34___ Disturbed menstrual cycle
35___ Weight change that you cannot control (gain or loss)
36___ Unusual irritability or new onset of depression
37___ New onset of anxiety or panic disorder
38___   Feelings of hopelessness or suicide
39___ Other (write in): ____________________________